Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2024
Gengnian'an Capsules fail microbial limit; manufacturer fined for producing inferior drugs
Gengnian'an Capsules produced by Yunnan Panlong Yunhai Pharmaceutical failed the microbial limit and were deemed inferior drugs. 10,655 boxes of the inferior drugs were confiscated and a fine was imposed.
2013
Paidu Yangyan Capsules suspected of concealing adverse reactions
Media questioned Panlong Yunhai's 'Paidu Yangyan Capsules', saying its so-called 'detox' was in fact a laxative, the instructions gave insufficient warnings about adverse reactions and contraindications, and long-term use carried a risk of laxative dependence. It sparked widespread controversy; no penalty was seen.